To require the Secretary of Health and Human Services to take no further action on proposed regulation relating to the use of chlorofluorocarbons in metered-dose inhalers.

Requires, in complying with specified provisions of the Clean Air Act and the Montreal Protocol on Substances that Deplete the Ozone Layer regarding chlorofluorocarbons (CFCs), that any regulations under which the essential use designations may be removed to phase out allowances for drug products require certification to the Congress that alternatives to inhalers are available that, for all user populations, are comparable in safety and effectiveness, therapeutic indications, dosage strength, cost, and retail availability. Requires withdrawal of a specified proposed rulemaking concerning CFCs in metered-dose inhalers. Regulates issuance of another proposal.